...
首页> 外文期刊>Epilepsy & behavior: E&B >Stimulation of the dorsal portion of subthalamic nucleus may be a viable therapeutic approach in pharmacoresistant epilepsy: A virally mediated transsynaptic tracing study in transgenic mouse model
【24h】

Stimulation of the dorsal portion of subthalamic nucleus may be a viable therapeutic approach in pharmacoresistant epilepsy: A virally mediated transsynaptic tracing study in transgenic mouse model

机译:刺激丘脑底核的背侧部分可能是耐药性癫痫的一种可行的治疗方法:在转基因小鼠模型中进行病毒介导的突触追踪研究

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Besides life-style changes, electrical stimulation or surgery, pharmacological treatment is becoming the first-choice approach in women suffering from lower urinary tract symptoms (LUTS), including urge urinary incontinence (UUI) and overactive bladder (OAB). Several drugs for the treatment of bladder storage and voiding disorders are currently available and, in the near future, novel compounds with higher specificity for the lower urinary tract receptors will be accessible. This will bring optimization of therapy, reducing side effects and increasing compliance, especially in patients with comorbidities and in women. The purpose of this paper is to give an overview on the pharmacotherapy of two common inter-correlated urological conditions, UUI and OAB. The study was conducted by analyzing and comparing the data of the recent international literature on this topic. Advances in the discovery of pharmacological options have dramatically improved the quality of life of patients affected by incontinence, but further studies are needed to increase the effectiveness and safety of the therapies used in this field.
机译:除了生活方式的改变,电刺激或手术之外,药物治疗正成为患有下尿路症状(LUTS)(包括急迫性尿失禁(UUI)和膀胱过度活动症(OAB))的女性的首选方法。当前可获得几种用于治疗膀胱存储和排尿障碍的药物,并且在不久的将来,将可获得对下尿路受体具有更高特异性的新型化合物。这将带来疗法的优化,减少副作用并增加依从性,尤其是在合并症患者和女性中。本文的目的是概述两种常见的相互关联的泌尿科疾病,UUI和OAB的药物治疗。该研究是通过分析和比较有关该主题的最新国际文献的数据进行的。药理学选择的发现进展已大大改善了失禁患者的生活质量,但是需要进一步的研究以提高该领域使用的疗法的有效性和安全性。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号